Literature DB >> 18294326

Fixed dose drug combinations (FDCs): rational or irrational: a view point.

Chandler S Gautam, Lekha Saha.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18294326      PMCID： PMC2432494          DOI： 10.1111/j.1365-2125.2007.03089.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

1.  The use of essential drugs. Model list of essential drugs (seventh list). Fifth report of the WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1992

2.  The use of essential drugs. Sixth report of the WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995
  2 in total
  22 in total

1.  Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics.

Authors:  Iliyas Khan; Gaurav Joshi; Kartik T Nakhate; Raj Kumar; Umesh Gupta
Journal:  Pharm Res       Date:  2019-08-16       Impact factor: 4.200

2.  Irrational fixed dose combinations & need for intervention: understanding of dental clinicians and residents.

Authors:  Kopal Sharma; Amit Sharma; Vikas Singh; Dinesh Pilania; Yogesh Kumar Sharma
Journal:  J Clin Diagn Res       Date:  2014-12-05

3.  Body of evidence and approaches applied in the clinical development programme of fixed-dose combinations in the European Union from 2010 to 2016.

Authors:  Asbjørn Nøhr-Nielsen; Marie Louise De Bruin; Mikael Thomsen; Christian Bressen Pipper; Theis Lange; Ole Jannik Bjerrum; Trine Meldgaard Lund
Journal:  Br J Clin Pharmacol       Date:  2019-06-17       Impact factor: 4.335

4.  Herbal Fixed Dose Combinations in Nepal: Growing Concerns in a Developing Country.

Authors:  Arjun Poudel; Kadir Alam; Subish Palaian; Mohamed Izham Mohamed Ibrahim
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 5.  Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems.

Authors:  Daniela Placha; Josef Jampilek
Journal:  Pharmaceutics       Date:  2021-01-06       Impact factor: 6.321

6.  Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study.

Authors:  Julie C Lauffenburger; Joan E Landon; Michael A Fischer
Journal:  J Gen Intern Med       Date:  2017-01-03       Impact factor: 5.128

7.  Comparison of analgesic effects of nimesulide, paracetamol, and their combination in animal models.

Authors:  Mushtaq Ahmed; Prerna Upadhyaya; Vikas Seth
Journal:  Indian J Pharmacol       Date:  2010-12       Impact factor: 1.200

8.  Antihypertensive use before and after initiation of fixed-dose combination products in Australia: a retrospective study.

Authors:  Svetla Gadzhanova; Jenni Ilomäki; Elizabeth E Roughead
Journal:  Int J Clin Pharm       Date:  2013-05-16

9.  Assessment of knowledge, attitude, and practices on fixed dose combinations among postgraduate dental students.

Authors:  Narayana R Vinnakota; V Krishna; V Viswanath; Zaheer Ahmed; Kamal S Shaik; Naveen K Boppana
Journal:  J Int Soc Prev Community Dent       Date:  2016-12

10.  Analgesic activity of fixed dose combinations of paracetamol with diclofenac sodium and paracetamol with tramadol on different pain models in healthy volunteers - A randomized double blind crossover study.

Authors:  Sachidanand Tripathi; Rima Shah; D C Sharma
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.